Revvity | PKI - Umsatzerlöse





Der Umsatz Veränderung Datum
Agilent USD 1.84B 37M 2026-03
Align Technology USD 1.04B 10M 2026-03
Bio Techne USD 311.4M 15.5M 2026-03
Bio-Rad Laboratories USD 592.1M 101.1M 2026-03
Bruker USD 823.4M 153.8M 2026-03
Celltrion KRW 1.15T 180B 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 28.31B 2.27B 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Illumina USD 1.09B 70M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
IQVIA Holdings USD 4.15B 210M 2026-03
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Laboratory Of America USD 3.54B 20M 2026-03
Medical Developments International AUD 21.57M 12.04M 2025-12
Mesa Laboratories USD 62.84M 5.01M 2024-12
Mettler Toledo International USD 947.13M 182.87M 2026-03
Myriad Genetics USD 200.4M 9.4M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Pharma Mar EUR 42.9M 47.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Quest Diagnostics USD 2.9B 90M 2026-03
Quidel USD 620M 104M 2026-03
Repligen USD 194M 3.91M 2026-03
Revvity USD 711M 61.06M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Tilray USD 217.51M 74.75M 2025-12
Waters USD 1.27B 338M 2026-03
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03